{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T17:48:17Z","timestamp":1786297697306,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.msard.2021.102807","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T21:51:01Z","timestamp":1612561861000},"page":"102807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil"],"prefix":"10.1016","volume":"50","author":[{"given":"Marco A.","family":"Lana-Peixoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2664-6534","authenticated-orcid":false,"given":"Nat\u00e1lia C.","family":"Talim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denison","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-9398","authenticated-orcid":false,"given":"J\u00e9ssica Marques","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Santiago-Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.msard.2021.102807_bib0001","doi-asserted-by":"crossref","first-page":"e79649","DOI":"10.1371\/journal.pone.0079649","article-title":"Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people","volume":"8","author":"Aboul-Enein","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.msard.2021.102807_bib0002","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2021.102807_bib0003","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of NMOSD in Australia and New Zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8-9","key":"10.1016\/j.msard.2021.102807_bib0004","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurol.2009.02.012","article-title":"Descriptive epidemiology of neuromyelitis optica in the Caribbean basin","volume":"165","author":"Cabre","year":"2009","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"10.1016\/j.msard.2021.102807_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-Gomez","year":"2009","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.msard.2021.102807_bib0006","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in South East Wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.msard.2021.102807_bib0007","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.msard.2015.08.004","article-title":"Prevalence of multiple sclerosis in Brazil: A systematic review","volume":"4","author":"da Gama Pereira","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2021.102807_bib0008","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2021.102807_bib0009","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.msard.2021.102807_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102425","article-title":"Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001-2015","volume":"45","author":"Fang","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.msard.2021.102807_bib0011","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.msard.2021.102807_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: Still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.msard.2021.102807_bib0012","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.msard.2021.102807_bib0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.msard.2021.102807_bib0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"19","key":"10.1016\/j.msard.2021.102807_bib0015","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","volume":"89","author":"Houzen","year":"2017","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102807_bib0016","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.08.032","article-title":"Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan","volume":"323","author":"Houzen","year":"2012","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.msard.2021.102807_bib0017","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","article-title":"The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom","volume":"260","author":"Jacob","year":"2013","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102807_bib0018","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.msard.2021.102807_bib0019","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1212\/WNL.0000000000007746","article-title":"Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study","volume":"93","author":"Jonsson","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2021.102807_bib0020","first-page":"204","article-title":"A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province","volume":"14","author":"Kashipazha","year":"2015","journal-title":"Iran. Iran J Neurol"},{"issue":"4","key":"10.1016\/j.msard.2021.102807_bib0021","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/0004-282x20190031","article-title":"HLA-alleles class I and II associated with genetic susceptibility to neuromyelitis optica in Brazilian patients","volume":"77","author":"Kay","year":"2019","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.msard.2021.102807_bib0022","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea","author":"Kim","year":"2019","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.msard.2021.102807_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2021.102807_bib0023","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1590\/S0004-282X2012000200006","article-title":"The prevalence of multiple sclerosis in Belo Horizonte","volume":"70","author":"Lana-Peixoto","year":"2012","journal-title":"Brazil. Arq Neuropsiquiatr"},{"issue":"2","key":"10.1016\/j.msard.2021.102807_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7020042","article-title":"Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes","volume":"7","author":"Lana-Peixoto","year":"2019","journal-title":"Biomedicines"},{"issue":"17","key":"10.1016\/j.msard.2021.102807_bib0025","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3346\/jkms.2020.35.e115","article-title":"Prevalence and Incidence of Neuromyelitis Optica Spectrum Disorder in Korea: Population Based Study","volume":"35","author":"Lee","year":"2020","journal-title":"J Korean Med Sci"},{"issue":"6","key":"10.1016\/j.msard.2021.102807_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/jnnp-2017-317321","article-title":"Nationwide epidemiological study of neuromyelitis optica in Japan","volume":"89","author":"Miyamoto","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2021.102807_bib0027","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jnnp-2017-317566","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorders","volume":"89","author":"Mori","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.msard.2021.102807_bib0028","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2021.102807_bib40","doi-asserted-by":"crossref","first-page":"102082","DOI":"10.1016\/j.msard.2020.102082","article-title":"Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?","volume":"42","author":"Papais Alvarenga","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.msard.2021.102807_bib0029","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ene.14079","article-title":"A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary","volume":"27","author":"Papp","year":"2020","journal-title":"Eur J Neurol"},{"issue":"24","key":"10.1016\/j.msard.2021.102807_bib0030","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2021.102807_bib0031","doi-asserted-by":"crossref","first-page":"e17063","DOI":"10.1371\/journal.pone.0017063","article-title":"The genomic ancestry of individions of Brazil is more uniform than expected","volume":"16","author":"Pena","year":"2011","journal-title":"PLoS One Feb"},{"issue":"5","key":"10.1016\/j.msard.2021.102807_bib0032","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic's disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102807_bib0033","doi-asserted-by":"crossref","first-page":"13706","DOI":"10.1038\/s41598-020-69224-3","article-title":"Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population","volume":"10","author":"Romero-Hidalgo","year":"2020","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.msard.2021.102807_bib0034","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates","volume":"24","author":"Sepulveda","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2021.102807_bib0035","article-title":"Epidemiological findings in neuromyelitis spectrum disorder in a Venezuelan study","author":"Soto de Castillo","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.msard.2021.102807_bib0036","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.msard.2021.102807_bib0037","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:51:18Z","timestamp":1761900678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"alternative-id":["S2211034821000730"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102807","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102807"}}